Through a number of dry and wet experiments, we have demonstrated that SPINK1 could act as a potential biomarker for the early detection, targeted therapeutics, and the prediction of ICB response in the management of HCC. This evidence concerns the gene SPINK1 and hepatocellular carcinoma.